From Casetext: Smarter Legal Research

Edgar v. Teva Pharm. Indus.

United States District Court, District of Kansas
Jul 24, 2024
No. 22-2501-DDC-TJJ (D. Kan. Jul. 24, 2024)

Opinion

22-2501-DDC-TJJ

07-24-2024

KEIKO EDGAR, DENA BURGE, LEIGH HOCKETT, JORDAN FURLAN, GINA GILOMEN-STUDY, UHA HEALTH INSURANCE, ANNE ARUNDEL COUNTY, MARYLAND and ROGERS MACHINERY COMPANY, INC., individually and on behalf of all others similarly situated, Plaintiffs, v. TEVA PHARMACEUTICALS INDUSTRIES, LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PARENTERAL MEDICINES, INC., TEVA NEUROSCIENCE, INC., TEVA SALES & MARKETING, INC., and CEPHALON, INC., Defendants.


MEMORANDUM AND ORDER

DANIEL D. CRABTREE UNITED STATES DISTRICT JUDGE

Plaintiffs have moved the court to clarify its decision on defendants' Motion to Dismiss. Doc. 77. Plaintiffs assert that they can't tell whether the court's Memorandum and Order dismissed their antitrust claims under California's Cartwright Act. Id. at 1. The court grants plaintiffs' motion, offering the following clarification.

Plaintiffs' Amended Complaint asserts claims for restraint of trade (Count V) and monopolization (Count VI) under various state laws. Doc. 42 at 55-58, 58-61 (1st Am. Compl. ¶¶ 250-60, 261-67). Those various state laws include two California laws: California's Unfair Competition Law and California's Cartwright Act. Id. at 57, 59 (1st Am. Compl. ¶¶ 258.c., 266.c.). These two laws do different things. California's Unfair Competition Law is a consumer protection statute. See Anunziato v. eMachines, Inc., 402 F.Supp.2d 1133, 1137 (C.D. Cal. 2005) (“The goal of . . . the UCL . . . is the protection of consumers.”). In contrast, California's Cartwright Act is an antitrust statute. See Asahi Kasei Pharma Corp. v. CoTherix, Inc., 204 Cal.App.4th 1, 7-8 (2012) (explaining history of Cartwright Act, “which generally outlaws any combinations or agreements which restrain trade or competition or which fix or control prices.” (quotation cleaned up)).

Defendants moved to dismiss “Plaintiffs' consumer-protection claims under California . . . law” for “fail[ure] to allege the requisite intrastate connection.” Doc. 47 at 48. Defendants argued that, like “a number of antitrust claims, [plaintiffs'] consumer protectionclaim under California . . . law fail[s] for lack of sufficient intrastate conduct or significant nexus.” Id. The court granted defendants' request to dismiss these claims because plaintiffs failed to respond and failed to plead a sufficient nexus with California. Doc. 74 at 69-70.

Plaintiffs' Motion for Clarification argues that defendants only moved to dismiss the consumer protection claims under California's Unfair Competition Law-not the Cartwright Act claims. Doc. 77 at 2. The court agrees. Defendants argue that plaintiffs' Cartwright Act claims fail because they lack a sufficient nexus with California, so the same rationale applies, and the court should dismiss the claims sua sponte. But the court rarely grants relief that a party neglects to request, nor is it willing to give defendants a second opportunity at dismissal. Plaintiffs' Cartwright Act claims thus remain.

IT IS THEREFORE ORDERED BY THE COURT THAT plaintiffs' Motion for Clarification (Doc. 77) is granted.

IT IS SO ORDERED.


Summaries of

Edgar v. Teva Pharm. Indus.

United States District Court, District of Kansas
Jul 24, 2024
No. 22-2501-DDC-TJJ (D. Kan. Jul. 24, 2024)
Case details for

Edgar v. Teva Pharm. Indus.

Case Details

Full title:KEIKO EDGAR, DENA BURGE, LEIGH HOCKETT, JORDAN FURLAN, GINA GILOMEN-STUDY…

Court:United States District Court, District of Kansas

Date published: Jul 24, 2024

Citations

No. 22-2501-DDC-TJJ (D. Kan. Jul. 24, 2024)